Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi-Drug Resistant Tuberculosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05017324
What this trial is testing

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial

Who this might be right for
Rifampicin Resistant TuberculosisDrug-resistant TuberculosisMultidrug Resistant Tuberculosis+1 more
Universiteit Antwerpen 248
Not applicableStudy completedNCT02413931
What this trial is testing

Nosocomial Transmission of MDR-TB in Bucharest, Romania

Who this might be right for
Tuberculosis, Multidrug-resistant
Research Center Borstel 53
Post-approval studies (Phase 4)Study completedNCT05278988
What this trial is testing

Ultrashort PRS Regimen V in the Treatment of MDR-TB

Who this might be right for
MDR-TB
Shanghai Pulmonary Hospital, Shanghai, China 60
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Not applicableLooking for participantsNCT05633056
What this trial is testing

An Adaptive Randomized Controlled Trial

Who this might be right for
Multi Drug Resistant TuberculosisHIV Infections
Columbia University 360
Large-scale testing (Phase 3)Study completedNCT03086486
What this trial is testing

Various Doses and Durations of Linezolid Plus Bedaquiline & Pretomanid in Participants With Drug Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+4 more
Global Alliance for TB Drug Development 181
Large-scale testing (Phase 3)Study completedNCT02754765
What this trial is testing

Evaluating Newly Approved Drugs for Multidrug-resistant TB

Who this might be right for
Tuberculosis, Multidrug-ResistantInfection, BacterialPulmonary Tuberculoses
Médecins Sans Frontières, France 754
Not applicableLooking for participantsNCT05117788
What this trial is testing

Bioneer Q-RFIA Clinical Evaluation

Who this might be right for
Tuberculosis, Multidrug-Resistant
Foundation for Innovative New Diagnostics, Switzerland 2,350
Testing effectiveness (Phase 2)Study completedNCT00727844
What this trial is testing

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Who this might be right for
Pulmonary TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 41
Not applicableStudy completedNCT02727582
What this trial is testing

Pharmacometric Optimization of Second Line Drugs for MDR Tuberculosis Treatment

Who this might be right for
Multidrug-resistant Tuberculosis
University of Cape Town 142
Not applicableActive Not RecruitingNCT02129244
What this trial is testing

A Nurse Case Management Intervention to Improve MDR-TB/HIV Co-Infection Outcomes

Who this might be right for
MDR-TBHIV
Johns Hopkins University 3,600
Post-approval studies (Phase 4)Study completedNCT03867136
What this trial is testing

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

Who this might be right for
Multidrug Resistant Tuberculosis
Huashan Hospital 354
Large-scale testing (Phase 3)Not Yet RecruitingNCT07675954
What this trial is testing

A 6-Month MDR-END Plus Regimen for Rifampicin-Resistant Tuberculosis

Who this might be right for
Rifampicin-Resistant Tuberculosis
Seoul National University Hospital 294
Large-scale testing (Phase 3)Study completedNCT02589782
What this trial is testing

Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)

Who this might be right for
Tuberculosis, Multidrug-ResistantExtensively Drug-Resistant TuberculosisTuberculosis, Pulmonary
Medecins Sans Frontieres, Netherlands 552
Not applicableEnded earlyNCT04783727
What this trial is testing

PredictEndTB Signature for Individualizing Treatment in Multidrug-Resistant Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantBacterial Infections+1 more
Research Center Borstel 4
Testing effectiveness (Phase 2)Study completedNCT02573350
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Efficacy of Orally Administered OPC-67683

Who this might be right for
Tuberculosis, Multidrug-Resistant
Otsuka Pharmaceutical Development & Commercialization, Inc. 213
Testing effectiveness (Phase 2)Looking for participantsNCT05534750
What this trial is testing

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

Who this might be right for
TuberculosisMultidrug Resistant Tuberculosis
Assistance Publique - Hôpitaux de Paris 60
Not applicableLooking for participantsNCT01212003
What this trial is testing

Training Protocol on the Natural History of Tuberculosis

Who this might be right for
Mycobacterium InfectionsTuberculosis, Multidrug-ResistantLatent Tuberculosis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 150
Large-scale testing (Phase 3)Looking for participantsNCT06905522
What this trial is testing

A PAN-USR TB Multi-Center Trial

Who this might be right for
Pulmonary Tuberculosis
Shenzhen Third People's Hospital 610
Large-scale testing (Phase 3)UnknownNCT03069534
What this trial is testing

Study of Adjunctive Recombinant Human Interleukin-2 Therapy in Patients With MDR-TB

Who this might be right for
MDR TB
The First Affiliated Hospital with Nanjing Medical University 500
Next Page